The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...
A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...
The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...
Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...
Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. David Kindness is a Certified Public Accountant (CPA) and an ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation ...
Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...
Focused shockwave therapy (fESWT) in thumb carpometacarpal joint osteoarthritis: A single case study
The final, formatted version of the article will be published soon. Background: Several studies have demonstrated the efficacy of shock wave therapy in managing OA-related pain and improving joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback